Title

Antenatal and intrapartum nucleic acid amplification test use for group B Streptococcus screening—United States, 2016

Document Type

Article

Publication Date

6-1-2019

Publication Title

Diagnostic Microbiology and Infectious Disease

Abstract

© 2018 Elsevier Inc. Perinatal group B Streptococcus (GBS) disease prevention guidelines in 2010 allowed for processing of screening specimens by nucleic acid amplification tests (NAATs); however, the extent of NAAT use is unknown. A 2016 laboratory survey sent to 10 surveillance sites found that 18.7% of responding laboratories offered NAAT for GBS screening (antenatal only: 7.3%; intrapartum only: 4.1%; both: 3.4%).

Volume

94

Issue

2

First Page

157

Last Page

159

DOI

10.1016/j.diagmicrobio.2018.11.026

ISSN

07328893

This document is currently not available here.

Share

COinS